These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 18710804

  • 1. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C, Giraud A, Provot O, Hamze A, Bignon J, Liu JM, Thoret S, Dubois J, Brion JD, Alami M.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3266-71. PubMed ID: 18477509
    [Abstract] [Full Text] [Related]

  • 3. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 01; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J, Pontikis R, Florent JC, Monneret C.
    Org Biomol Chem; 2005 Jul 21; 3(14):2657-60. PubMed ID: 15999202
    [Abstract] [Full Text] [Related]

  • 5. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR, Minardi MD, Rosenberg HJ, Hamel E, Bibby MC, Martin SW, Jung MK, Pettit RK, Cuthbertson TJ, Chapuis JC.
    J Nat Prod; 2005 Oct 21; 68(10):1450-8. PubMed ID: 16252907
    [Abstract] [Full Text] [Related]

  • 6. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK.
    J Med Chem; 2005 Jun 16; 48(12):4087-99. PubMed ID: 15943482
    [Abstract] [Full Text] [Related]

  • 7. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K, Hentzen J, dit Chabert JF, Ducki S, Gani OA, Sylte I, Skrede M, Flørenes VA, Hansen TV.
    Bioorg Med Chem; 2008 May 01; 16(9):4829-38. PubMed ID: 18396050
    [Abstract] [Full Text] [Related]

  • 8. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I, Carr M, O'Boyle N, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ.
    J Enzyme Inhib Med Chem; 2010 Apr 01; 25(2):180-94. PubMed ID: 20222762
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.
    Aziz J, Brachet E, Hamze A, Peyrat JF, Bernadat G, Morvan E, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Tueni M, Yassine A, Brion JD, Alami M.
    Org Biomol Chem; 2013 Jan 21; 11(3):430-42. PubMed ID: 23047722
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins.
    Lipeeva AV, Shults EE, Shakirov MM, Pokrovsky MA, Pokrovsky AG.
    Molecules; 2014 Jun 11; 19(6):7881-900. PubMed ID: 24962392
    [Abstract] [Full Text] [Related]

  • 11. Solution-phase parallel synthesis and biological evaluation of combretatriazoles.
    Cafici L, Pirali T, Condorelli F, Del Grosso E, Massarotti A, Sorba G, Canonico PL, Tron GC, Genazzani AA.
    J Comb Chem; 2008 Jun 11; 10(5):732-40. PubMed ID: 18681482
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
    O'Boyle NM, Carr M, Greene LM, Bergin O, Nathwani SM, McCabe T, Lloyd DG, Zisterer DM, Meegan MJ.
    J Med Chem; 2010 Dec 23; 53(24):8569-84. PubMed ID: 21080725
    [Abstract] [Full Text] [Related]

  • 13. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M, Maya AB, Pérez-Melero C.
    J Enzyme Inhib Med Chem; 2004 Dec 23; 19(6):521-40. PubMed ID: 15662956
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and bioactivity of putative tubulin ligands with adamantane core.
    Zefirova ON, Nurieva EV, Lemcke H, Ivanov AA, Shishov DV, Weiss DG, Kuznetsov SA, Zefirov NS.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5091-4. PubMed ID: 18715782
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
    Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG.
    Bioorg Med Chem; 2006 May 01; 14(9):3231-44. PubMed ID: 16442292
    [Abstract] [Full Text] [Related]

  • 16. Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.
    Tanpure RP, Strecker TE, Chaplin DJ, Siim BG, Trawick ML, Pinney KG.
    J Nat Prod; 2010 Jun 25; 73(6):1093-101. PubMed ID: 20496923
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4.
    Zhou J, Zhang Y, Cui YW, Li ZM, Song HR, Dong JH, Chen XG, Xu BL.
    J Asian Nat Prod Res; 2011 Apr 25; 13(4):330-40. PubMed ID: 21462036
    [Abstract] [Full Text] [Related]

  • 18. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY, Yang MF, Chang CY, Chen CM, Kuo CC, Liou JP.
    J Med Chem; 2006 Oct 19; 49(21):6412-5. PubMed ID: 17034147
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T, Mikstacka R, Kurczab R, Dutkiewicz Z, Kucińska M, Murias M, Zielińska-Przyjemska M, Cichocki M, Teubert A, Kaczmarek M, Hogendorf A, Sobiak S.
    Eur J Med Chem; 2018 Jan 20; 144():797-816. PubMed ID: 29291446
    [Abstract] [Full Text] [Related]

  • 20. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
    Borrel C, Thoret S, Cachet X, Guénard D, Tillequin F, Koch M, Michel S.
    Bioorg Med Chem; 2005 Jun 01; 13(11):3853-64. PubMed ID: 15863010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.